Interestingly, editing efficiencies at sites B, C, and E in phosphodiesterase 8A (PDE8A), a key modulator of signal transduction downstream of 5-HT2C, were decreased in the brain and blood of patients with depression [100,101]. Here, PDE8A is linked to depressive symptom measurement.